Strata Critical Medical (SRTA) Change in Acquisitions & Divestments (2023 - 2026)

Strata Critical Medical has disclosed Change in Acquisitions & Divestments across 4 years of filings, most recently posting $30.5 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 71.69% year-over-year to $30.5 million; the TTM figure through Mar 2026 stood at -$7.1 million (down 241.46% YoY), while the FY2025 annual figure was $70.2 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments grew to $30.5 million in Q1 2026, from -$132.8 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for SRTA reached as high as $131.2 million in Q1 2023 and fell as low as -$168.0 million in Q4 2024.
• The 4-year median for Change in Acquisitions & Divestments is $47.6 million (2025), against an average of $12.1 million.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments increased 20.91% — and 2026, when it plunged 71.69%.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at -$110.7 million in 2023, then sank by 51.78% to -$168.0 million in 2024, then advanced by 20.91% to -$132.8 million in 2025, then soared by 122.96% to $30.5 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $30.5 million, -$132.8 million, and $51.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.